Skip to main content

Table 1 Characteristics of Study Population

From: Elevated level of the soluble receptor for advanced glycation end-products involved in sarcopenia: an observational study

Variables Male(n = 137) Female(n = 177) P value
Continuous variable (mean ± SD)a
Age (years) 73.12 ± 8.41 71.82 ± 7.49 0.148
Grip strength (kg) 33.86 ± 8.05 20.23 ± 5.26 < 0.001
SMI (ALM/ht2)(kg/m2) 7.26 ± 0.79 5.79 ± 0.66 < 0.001
Gait speed(m/s) 1.13 ± 0.34 1.09 ± 0.30 0.330
Number of comorbidity. 0.77 ± 0.93 0.76 ± 1.02 0.922
AGE(μg/mL) 37.65 ± 17.80 37.48 ± 16.45 0.933
RAGE(pg/ml) 1204.24 ± 496.12 1280.28 ± 568.82 0.236
Categorical variable (%)b
HTN 39.4% 31.1% 0.124
DM 10.9% 14.1% 0.403
MI 1.5% 0.6% 0.419
Angina 0.7% 1.1% 0.718
CAD 10.9% 5.1% 0.052
COPD 2.9% 5.6% 0.245
  1. Abbreviations: AGE Advanced glycation end products, sRAGE soluble receptor for advanced glycation end-products, SMI skeletal muscle mass index, HTN hypertension, DM diabetes mellitus, MI myocardial infarction, CAD coronary artery disease, COPD chronic obstructive pulmonary disease
  2. aValues in the continuous variables were expressed as mean and standard deviation
  3. bValues in the categorical variables were expressed in number and percentage (%)
  4. Pearson’s chi-square test was applied for comparison of categorical variables, whereas ANOVA (Analysis of Variance) was applied for comparison of continuous variables